AMANDA DARU: Open Payments
NPI 1164117065 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 25 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $105 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $163 |
| Otsuka America Pharmaceutical, Inc. | 6 | $142 |
| Lilly USA, LLC | 4 | $105 |
| Lundbeck LLC | 3 | $78 |
| Exact Sciences Corporation | 3 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| ABBVIE INC. | 1 | $26 |
Products named: REXULTI, Ozempic, Rybelsus, MOUNJARO, JARDIANCE, Cologuard Collection Kit, SYNTHROID.
Industry payments across NY — which companies pay providers there.
